Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Challenge of Determining the Etiology of Encephalopathy in an Elderly Patient.

Clinical case reports·2026

Same author

Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Reviews in endocrine & metabolic disorders·2026

Same author

Traditional and Modern Predictors of Atherosclerotic Cardiovascular Disease in Patients with T2D and MASLD.

Diagnostics (Basel, Switzerland)·2026

Same author

Healthcare costs of COVID-19 hospitalization in maintenance hemodialysis patients during the first two pandemic waves in Romania: a retrospective cohort study.

Journal of medicine and life·2026

Same author

Lipid Signatures Associated with Diabetic Peripheral Neuropathy in Obesity and Type 2 Diabetes-A Systematic Review.

Journal of clinical medicine·2026

Same author

MASLD and Atherosclerosis in Patients with Type 2 Diabetes Mellitus: A Systematic Review.

Medicina (Kaunas, Lithuania)·2026

Search research articles

Related Experiment Video

Updated: Jan 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Treatment with Statins in Elderly Patients.

Ruxandra-Nicoleta Horodinschi^1,2, Ana Maria Alexandra Stanescu³, Ovidiu Gabriel Bratu^4,5

¹University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania. ruxy691@yahoo.com.

Medicina (Kaunas, Lithuania)

|November 2, 2019

Summary

Statins effectively reduce cardiovascular events like heart attack and stroke in elderly patients. However, potential side effects necessitate careful consideration of benefits versus risks, especially with high doses.

Keywords:

atherosclerosis elderly myocardial infarction statin stroke

Related Experiment Videos

Last Updated: Jan 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

Gerontology
Cardiology
Pharmacology

Background:

Elderly patients present unique challenges due to age-related physiological changes, comorbidities, and cognitive decline.
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in older adults globally.
Atherosclerosis underlies major cardiovascular events such as myocardial infarction and stroke, with incidence increasing with age.

Purpose of the Study:

To review the efficacy and safety of statin therapy in elderly patients for atherosclerotic cardiovascular disease.
To emphasize the importance of primary and secondary prevention strategies for CVD in this population.
To discuss the balance between statin benefits and risks in the elderly.

Main Methods:

Literature review on statin use in elderly populations for cardiovascular disease prevention.
Analysis of data regarding the efficacy of statins in reducing cardiovascular events.
Evaluation of potential side effects and drug interactions associated with statin therapy in older adults.

Main Results:

Statins are the most effective treatment for atherosclerosis, significantly decreasing the risk of stroke and coronary artery disease across all age groups.
Benefits of statin therapy become apparent after at least one year of continuous treatment.
Elderly patients are at higher risk for statin-related side effects, including diabetes mellitus, myopathy, and hepatotoxicity, due to comorbidities and polypharmacy.

Conclusions:

Primary prevention through healthy lifestyle and risk factor reduction is crucial for elderly individuals.
Secondary prevention following a cardiovascular event mandates statin use to prevent recurrence.
The decision to use statins in the elderly requires a careful balance of proven benefits against potential risks, particularly when high doses are considered.